Histogen Inc.
HSTO · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | -0.00 | 0.00 |
| FCF Yield | -3,714.27% | -1,167.01% | -1,765.84% | -30.54% |
| EV / EBITDA | 0.69 | 0.85 | 0.04 | -0.98 |
| Quality | ||||
| ROIC | -58.85% | -61.70% | -94.77% | -836.21% |
| Gross Margin | 100.00% | 76.06% | 52.99% | 79.35% |
| Cash Conversion Ratio | 0.91 | 0.97 | 0.64 | 0.43 |
| Growth | ||||
| Revenue 3-Year CAGR | 22.33% | -56.87% | -60.57% | -31.33% |
| Free Cash Flow Growth | 32.99% | -22.06% | -738.74% | 95.88% |
| Safety | ||||
| Net Debt / EBITDA | 0.71 | 0.94 | 0.08 | 0.67 |
| Interest Coverage | -10,643.00 | -1,545.70 | -183.03 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.13 | 3.23 | 20.90 |
| Cash Conversion Cycle | 9.59 | 1,039.48 | -64.59 | -112.17 |